High-dose simultaneously integrated breast boost using intensity-modulated radiotherapy and inverse optimization
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation
Reference29 articles.
1. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer;Fisher;N Engl J Med,1995
2. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial;Forrest;Lancet,1996
3. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial;Liljegren;J Clin Oncol,1999
4. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation;Bartelink;N Engl J Med,2001
5. Bartelink H, Boersma LJ, Leer JW, Poortmans P. Radiation dose intensity study in breast cancer in young women: a randomized phase III trial of additional dose to the tumor bed. 6–8–2004. Boog 2004–1, CKTO 2003–13.
Cited by 78 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hypofractionated radiotherapy with simultaneous tumor bed boost (Hi-RISE) in breast cancer patients receiving upfront breast-conserving surgery: study protocol for a phase III randomized controlled trial;Radiation Oncology;2024-05-27
2. Hypofractionated radiotherapy with simultaneous tumor bed boost (Hi-RISE) in breast cancer patients receiving upfront breast-conserving surgery: study protocol for a phase III randomized controlled trial;2024-02-07
3. Noninferiority of Local Control and Comparable Toxicity of Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Breast Cancer: 5-Year Results of the IMRT-MC2 Phase III Trial;International Journal of Radiation Oncology*Biology*Physics;2023-11
4. Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study;Radiation Oncology Journal;2022-06-30
5. Comparison of Heart and Lung Doses According to Tumor Bed Boost Techniques in Early-Stage Left-Sided Breast Cancer: Simultaneous Integrated Boost versus Sequential Boost;Medicina;2022-06-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3